Quantum Blue® Adalimumab
The biologic drug Adalimumab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN Quantum Blue® Adalimumab is the first rapid test to measure adalimumab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.
Quantum Blue® Anti-Adalimumab
The presence of anti-drug antibodies (ADA) against adalimumab can diminish the clinically beneficial effect of the drug. The Quantum Blue® Anti-Adalimumab rapid test allows for reliable detection of antibodies against adalimumab within 15 min.
Quantum Blue® Infliximab
The biologic drug Infliximab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN Quantum Blue® Infliximab is the first rapid test to measure infliximab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.
Quantum Blue® Anti-Infliximab
The presence of anti-drug antibodies (ADA) against infliximab can diminish the clinically beneficial effect of the drug. The Quantum Blue® Anti-Infliximab rapid test allows for a highly specific detection of antibodies against infliximab within 15 min.
Social Links